The effect of Lavandula Angustifolia MlLL in the treatment of mild to moderate depression

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138810302085N1

Enrollment

Registered

2010-05-30

Start date

2008-08-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild to moderate depression. Depressive episode

Interventions

Intervention 1: Citalopram, 20mg as well as placebo twice daily for 2 months. Intervention 2: Citalopram, 20 mg as well as 5 gr aerial part of Lavandula twice daily for 2 months.

Placebo

Treatment - Drugs

Citalopram, 20mg as well as placebo twice daily for 2 months.

Citalopram, 20 mg as well as 5 gr aerial part of Lavandula twice daily for 2 months

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Presence of major depression Exclusion criteria: allergy to lavanda, presence of psychosis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Depression severity. Timepoint: Baseline and 4 and 8 weeks after the intervention. Method of measurement: depression standard Hamilton's questionnaire.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026